naftopidil has been researched along with Acute Bacterial Prostatitis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the efficacy and safety of alpha1 adrenoceptor antagonist Naftopidil in the treatment of chronic non-bacterial prostatitis." | 9.12 | [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis]. ( Cai, SL; Chen, SP; Chen, SY; Ding, Q; Gu, XJ; Huo, HX; Li, NC; Li, X; Na, YQ, 2006) |
| "We investigated the effect of naftopidil an alpha1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS)." | 7.76 | [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment]. ( Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A, 2010) |
| "To study the efficacy and safety of alpha1 adrenoceptor antagonist Naftopidil in the treatment of chronic non-bacterial prostatitis." | 5.12 | [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis]. ( Cai, SL; Chen, SP; Chen, SY; Ding, Q; Gu, XJ; Huo, HX; Li, NC; Li, X; Na, YQ, 2006) |
| "We investigated the effect of naftopidil an alpha1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS)." | 3.76 | [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment]. ( Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, A | 1 |
| Ohinata, M | 1 |
| Fujishima, M | 1 |
| Hirano, S | 1 |
| Kudou, T | 1 |
| Funaki, H | 1 |
| Akasaka, T | 1 |
| Watanabe, T | 1 |
| Inoue, M | 1 |
| Sasaki, K | 1 |
| Araki, M | 1 |
| Uehara, S | 1 |
| Monden, K | 1 |
| Saika, T | 1 |
| Nasu, Y | 1 |
| Kumon, H | 1 |
| Chancellor, MB | 1 |
| Li, X | 1 |
| Li, NC | 1 |
| Ding, Q | 1 |
| Cai, SL | 1 |
| Huo, HX | 1 |
| Chen, SY | 1 |
| Gu, XJ | 1 |
| Chen, SP | 1 |
| Na, YQ | 1 |
1 trial available for naftopidil and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
[Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Humans; Male; Middle Aged; Naphtha | 2006 |
2 other studies available for naftopidil and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Chronic Disease; Drug A | 2010 |
Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Biomarkers; Bodily Secretions; Enzyme-Linked Immunosorben | 2011 |